title: Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.
abstract: We designed the present case-control study in order to examine the validity of apolipoprotein (apo) A-I, B, apoB/apoA-I ratio and Lp(a) as alternative markers of cardiovascular morbidity in end-stage renal disease (ESRD) patients undergoing chronic hemodialysis (HD). Twenty-five HD patients (18 males, mean age 63, range 52-69 years) comprised the group with prevalent cardiovascular disease (CVD) and 50 HD patients (35 males, mean age 62, range 40-77 years) with non evident cardiovascular disease history constituted the second study group. Patients with CVD had significantly higher concentrations of serum apoB, apoB/apoA-I ratio and Lp(a), and lower levels of apoA-I compared to patients without incident CVD. All three parameters studied were correlated with cardiovascular morbidity, i.e. apoA-I negatively and apoB and apoB/apoA-I ratio positively (r = -0.6, P < 0.05; r = 0.659, P < 0.01; and r = 0.614, P < 0.01, respectively). Furthermore, logCRP exhibited as well a significant positive correlation with cardiovascular morbidity (r = 0.704, P < 0.001), not this being the case for Lp(a) which was not found to exhibit such a correlation (r = 0.05, P = NS). Among them, apoB and apoB/apoA-I ratio exhibited the characteristics most coherent to CVD. The age- and sex-adjusted OR for the presence of CVD was 2.3 and 2.0, respectively, which remained independent of any confounding effect of inflammation. In conclusion, serum apoB levels and apoB/apoA-I ratio exhibit characteristics of credible independent markers of in HD patients.
authors.affiliation: Department of Nephrology, Serres General Hospital, Serres, Greece.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Kirmizis
authors.forename: Evangelia
authors.initials: E
authors.lastname: Koutoupa
authors.forename: Apostolos
authors.initials: A
authors.lastname: Tsiandoulas
authors.forename: Aphroditi
authors.initials: A
authors.lastname: Valtopoulou
authors.forename: Georgios
authors.initials: G
authors.lastname: Niavis
authors.forename: Phani
authors.initials: P
authors.lastname: Markou
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Barboutis
references.citation: Circulation. 2004 Jul 13;110(2):227-39
references.pmid: 15249516
references.citation: Atherosclerosis. 2003 Nov;171(1):145-55
references.pmid: 14686332
references.citation: Kidney Int. 2002 Jan;61(1):209-18
references.pmid: 11786103
references.citation: Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):553-9
references.pmid: 15618542
references.citation: J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S24-30
references.pmid: 11443765
references.citation: JAMA. 2004 Jan 28;291(4):451-9
references.pmid: 14747502
references.citation: Circulation. 2000 Feb 8;101(5):477-84
references.pmid: 10662743
references.citation: Circulation. 2004 Nov 2;110(18):2824-30
references.pmid: 15492318
references.citation: Diabetes Care. 2004 Aug;27(8):1991-7
references.pmid: 15277429
references.citation: QJM. 2006 May;99(5):277-87
references.pmid: 16504986
references.citation: Kidney Int. 2002 May;61(5):1887-93
references.pmid: 11967041
references.citation: Circulation. 2002 Mar 12;105(10):1162-9
references.pmid: 11889008
references.citation: Atherosclerosis. 2005 Apr;179(2):339-44
references.pmid: 15777551
references.citation: J Am Soc Nephrol. 1995 Jul;6(1):110-20
references.pmid: 7579063
references.citation: Atherosclerosis. 1983 Sep;48(3):279-88
references.pmid: 6579964
references.citation: Circulation. 2002 Nov 12;106(20):2526-9
references.pmid: 12427645
references.citation: Clin Chem Lab Med. 2004;42(12):1355-63
references.pmid: 15576296
references.citation: Circulation. 1992 Aug;86(2):475-82
references.pmid: 1386292
references.citation: J Lipid Res. 1994 May;35(5):779-92
references.pmid: 8071601
references.citation: Semin Dial. 2006 Jan-Feb;19(1):32-40
references.pmid: 16423180
references.citation: Circulation. 1998 Apr 21;97(15):1453-60
references.pmid: 9576425
references.citation: Arteriosclerosis. 1983 May-Jun;3(3):260-72
references.pmid: 6573877
references.citation: Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1918-23
references.pmid: 12426225
references.citation: Atherosclerosis. 1997 Jun;131(2):229-36
references.pmid: 9199276
references.citation: Circulation. 1999 May 18;99(19):2517-22
references.pmid: 10330382
references.citation: Am J Kidney Dis. 1990 May;15(5):458-82
references.pmid: 2333868
references.citation: N Engl J Med. 2005 Jul 7;353(1):46-57
references.pmid: 16000355
references.citation: Clin Nephrol. 1989 Feb;31(2):88-95
references.pmid: 2920472
references.citation: Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2408-13
references.pmid: 11073845
references.citation: J Am Soc Nephrol. 2003 Sep;14(9):2329-37
references.pmid: 12937310
references.citation: Circulation. 2000 Sep 5;102(10):1082-5
references.pmid: 10973834
references.citation: Lancet. 2001 Dec 15;358(9298):2026-33
references.pmid: 11755609
references.citation: Eur Heart J. 2005 Feb;26(3):271-8
references.pmid: 15618061
references.citation: JAMA. 2005 Jul 20;294(3):326-33
references.pmid: 16030277
references.citation: JAMA. 2001 May 16;285(19):2486-97
references.pmid: 11368702
references.citation: Circulation. 1996 Aug 1;94(3):273-8
references.pmid: 8759066
references.citation: Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S30-3
references.pmid: 11576918
references.citation: J Hypertens. 1999 Feb;17(2):151-83
references.pmid: 10067786
references.citation: Clin Chem. 1995 Feb;41(2):246-55
references.pmid: 7533064
references.citation: Lancet. 2004 Sep 11-17;364(9438):937-52
references.pmid: 15364185